Page 40 - Global Growth Pharmaceuticals & Biotech Stocks

UPDATED Sep 09, 2025

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,050 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
4540
Tsumura
JP¥3,807.001.7%-3.4%JP¥284.4bJP¥4,138.33PE11.1xE4.1%3.6%
LSTA
Lisata Therapeutics
US$2.20-0.5%-29.9%US$19.3mUS$20.67PS18xE4.1%n/a
FGEN
FibroGen
US$11.48-5.7%14.8%US$46.4mUS$43.00PS6.3xE3.8%n/a
ZBIO
Zenas BioPharma
US$21.8424.7%n/aUS$919.7mUS$31.57PS61.3xE3.8%n/a
ANIX
Anixa Biosciences
US$2.98-0.3%-6.0%US$95.7mUS$9.00PB6xE3.7%n/a
VIR
Vir Biotechnology
US$5.244.8%-34.3%US$727.9mUS$17.22PS38.3xE3.7%n/a
ACOG
Alpha Cognition
US$9.5515.1%-6.8%US$143.8mUS$20.00PS33.7xE3.6%n/a
KRKG
Krka d. d
€219.006.8%60.4%€6.6b€185.58PE17.6xE3.6%3.8%
CABA
Cabaletta Bio
US$1.6815.9%-61.8%US$155.5mUS$11.56PB0.9xE3.5%n/a
PYXS
Pyxis Oncology
US$1.9653.1%-45.4%US$118.5mUS$6.00PS43.1xE3.5%n/a
NEU
Neuren Pharmaceuticals
AU$20.203.0%46.3%AU$2.6bAU$24.51PE17.1xE3.4%n/a
PBH
Prestige Consumer Healthcare
US$65.79-3.3%-9.4%US$3.2bUS$82.80PE15.2xE3.3%n/a
4893
Noile-Immune Biotech
JP¥192.000%2.1%JP¥8.3bJP¥440.00PS923.8xE3.3%n/a
TOVX
Theriva Biologics
US$0.40-1.8%-89.7%US$3.8mUS$7.00PB0.4xE3.2%n/a
4528
Ono Pharmaceutical
JP¥1,745.002.2%-10.1%JP¥819.8bJP¥1,631.82PE19.1xE3.0%4.6%
IMTX
Immatics
US$5.798.4%-51.5%US$703.8mUS$13.67PS4.6xE3.0%n/a
HLUN B
H. Lundbeck
DKK 41.844.3%-8.5%DKK 39.9bDKK 48.18PE11.9xE3.0%2.3%
VETO
Vetoquinol
€73.000.3%-24.1%€861.1m€91.57PE14.7xE2.9%1.2%
APLT
Applied Therapeutics
US$0.44-15.4%-91.5%US$63.4mUS$3.17PS523.9xE2.9%n/a
ABCL
AbCellera Biologics
US$4.244.7%64.3%US$1.3bUS$9.33PS38.5xE2.9%n/a
688319
Chengdu Olymvax Biopharmaceuticals
CN¥27.48-4.8%222.2%CN¥11.2bCN¥27.55PE180.2xE2.8%0%
BOLT
Bolt Biotherapeutics
US$5.031.0%-60.2%US$9.7mUS$33.67PS2.3xE2.8%n/a
CIPLA
Cipla
₹1,551.60-1.1%-4.9%₹1.3t₹1,676.69PE23.2xE2.6%0.8%
FULC
Fulcrum Therapeutics
US$7.2412.9%-14.1%US$391.6mUS$11.07PB1.8xE2.6%n/a
Page 40 of 128